Infinity Pharmaceuticals Profile

2.03
USD 0.01  0.49%
17%
2.33
81%
2.05

Acquisition by Adelene Perkins of 500000 shares of Infinity Pharmaceuticals subject to Rule 16b-3

Infinity Pharmaceuticals Inc insider trading alert for grant of stock option (right to buy) by Adelene Perkins, Chief Executive Officer, on January 9, 2018. This event was filed by Infinity Pharmaceuticals with SEC on 2018-01-09. Statement of changes in beneficial ownership - SEC Form 4. Adelene Perkins is currently serves as chairman of the board, ceo and pres of Infinity Pharmaceuticals [view details]   

Infinity Pharmaceuticals Summary

Infinity Pharmaceuticals Inc (INFI) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 48 people. Infinity Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 103.96 M. Infinity Pharmaceuticals Inc has 50.71 M outstanding shares of which 1.98 M shares are currently shorted by private and institutional investors with about 1.06 trading days to cover. INFINITY PHARMACE currently holds about 55.58 M in cash with (58.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.1.
Check Infinity Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Acadian Asset Management LlcCommon Shares32.6 K66 K
Simplex Trading LlcCommon Shares28.4 K57 K
Cutler Group LpCall Options5000.0
Simplex Trading LlcPut Options22.00.0
View Infinity Pharmaceuticals Diagnostics

Selected Infinity Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Infinity Pharmaceuticals Against Markets

Current Ratings

Infinity Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
1 
Chance of
Financial Distress (0 to 100%)
< 12% 
Equity ratings for Infinity Pharmaceuticals Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Infinity Pharmaceuticals, Inc., a drug discovery and development company, discovers, develops, and delivers medicines to patients with difficulttotreat diseases. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameInfinity Pharmaceuticals Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationMASSACHUSETTS, U.S.A
Business Address784 Memorial Drive, Cambridge, MA 02139, United States
ExchangeNASDAQ
CIK Number01113148.0
CUSIP45665G303
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.infi.com
Contact Number617 453 1000
CurrencyUSD - US Dollar

Recommendations

Infinity Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
2.0Hold3Odds
Infinity Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Infinity Pharmaceuticals Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Infinity Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.56February 28, 2017
Infinity Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate